Actively Recruiting
Evaluation of a New Trifocal Intraocular Lens Compared to the Clareon PanOptix Pro Lens in Cataract Surgery
Led by Alcon Research · Updated on 2026-10-21
66
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare the visual outcomes of a new trifocal intraocular lens IOL model LPYWT0 with a commercially available trifocal IOL called Clareon PanOptix Pro Model PXYWT0. The study involves adults with cataracts in both eyes who are undergoing cataract surgery. The purpose is to understand how well each lens performs after surgery in terms of vision clarity. Participants will receive cataract surgery in both eyes. One eye will be implanted with the investigational LPYWT0 IOL and the other eye with the marketed PXYWT0 IOL. The second eye surgery will be scheduled between 7 and 14 days after the first eye surgery. The study is randomized so which eye receives which lens is determined by chance. The lenses are designed to stay in the eye permanently after implantation. During the study, participants will attend nine scheduled visits over about seven months. Researchers will assess vision using tests such as the Best Corrected Distance Visual Acuity at six months after surgery. Other evaluations will include eye exams and safety monitoring throughout the participation period. The study is conducted in India and the Philippines and aims to gather detailed data on the performance of these two lens types.
CONDITIONS
Brief Title
Clinical Evaluation of a Novel Trifocal IOL
Research Team
A
Alcon Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here